INHIBIKASE THERAPEUTICS, INC.

Transcripts Inhibikase Therapeutics, Inc.

Equities

IKT

US45719W2052

Market Closed - Nasdaq Other stock markets 21:00:00 16/05/2024 BST			5-day change	1st Jan Change
1.76 ^USD	-11.56%		+29.41%	+38.58%

05-16	Transcript : Inhibikase Therapeutics, Inc., Q1 2024 Earnings Call, May 16, 2024
05-09	Inhibikase Therapeutics Announces Final Pre-Ind Meeting Outcomes for Ikt-001Pro as A Treatment for Pulmonary Arterial Hypertension	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Inhibikase Therapeutics, Inc., Q1 2024 Earnings Call, May 16, 2024	05-16
Transcript : Inhibikase Therapeutics, Inc., 2023 Earnings Call, Mar 28, 2024	03-28
Transcript : Inhibikase Therapeutics, Inc., Q3 2023 Earnings Call, Nov 15, 2023	11-15
Transcript : Inhibikase Therapeutics, Inc., Q2 2023 Earnings Call, Aug 15, 2023	15/08/23
Transcript : Inhibikase Therapeutics, Inc., Q1 2023 Earnings Call, May 16, 2023	16/05/23
Transcript : Inhibikase Therapeutics, Inc., Q4 2022 Earnings Call, Apr 03, 2023	03/04/23
Transcript : Inhibikase Therapeutics, Inc. - Special Call	22/03/23
Transcript : Inhibikase Therapeutics, Inc., Q3 2022 Earnings Call, Nov 15, 2022	15/11/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer